Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2023 Oct 2;19(10):e1011707. doi: 10.1371/journal.ppat.1011707

Identification of IMC43, a novel IMC protein that collaborates with IMC32 to form an essential daughter bud assembly complex in Toxoplasma gondii

Rebecca R Pasquarelli 1, Peter S Back 1, Jihui Sha 2, James A Wohlschlegel 2, Peter J Bradley 1,3,*
Editor: Christopher J Tonkin4
PMCID: PMC10569561  PMID: 37782662

Abstract

The inner membrane complex (IMC) of Toxoplasma gondii is essential for all phases of the parasite’s life cycle. One of its most critical roles is to act as a scaffold for the assembly of daughter buds during replication by endodyogeny. While many daughter IMC proteins have been identified, most are recruited after bud initiation and are not essential for parasite fitness. Here, we report the identification of IMC43, a novel daughter IMC protein that is recruited at the earliest stages of daughter bud initiation. Using an auxin-inducible degron system we show that depletion of IMC43 results in aberrant morphology, dysregulation of endodyogeny, and an extreme defect in replication. Deletion analyses reveal a region of IMC43 that plays a role in localization and a C-terminal domain that is essential for the protein’s function. TurboID proximity labelling and a yeast two-hybrid screen using IMC43 as bait identify 30 candidate IMC43 binding partners. We investigate two of these: the essential daughter protein IMC32 and a novel daughter IMC protein we named IMC44. We show that IMC43 is responsible for regulating the localization of both IMC32 and IMC44 at specific stages of endodyogeny and that this regulation is dependent on the essential C-terminal domain of IMC43. Using pairwise yeast two-hybrid assays, we determine that this region is also sufficient for binding to both IMC32 and IMC44. As IMC43 and IMC32 are both essential proteins, this work reveals the existence of a bud assembly complex that forms the foundation of the daughter IMC during endodyogeny.

Author summary

Toxoplasma gondii is an obligate intracellular parasite that causes disease in immunocompromised individuals and congenitally infected neonates. Toxoplasma replicates using a unique process of internal budding in which two daughter buds form inside a single maternal parasite. This process is facilitated by an organelle called the inner membrane complex (IMC) which is found in Toxoplasma and other parasites in the phylum Apicomplexa. Although the IMC is known to be required for parasite replication, only a few early-recruiting IMC proteins have been identified. In this study, we identify and functionally analyze a novel IMC protein which is one of the earliest components of daughter buds and plays an essential role in parasite replication. We also identify its binding partners and demonstrate how their interactions impact the construction of daughter cells. This work reveals the existence of an essential protein complex formed in the earliest stages of parasite replication, expands our understanding of the IMC’s role in Toxoplasma replication, and identifies potential targets for therapeutic intervention.

Introduction

The Apicomplexa are a phylum of obligate intracellular parasites which cause serious disease in both humans and animals worldwide, leading to significant morbidity and mortality as well as economic losses [1]. The phylum includes the human pathogens Toxoplasma gondii (toxoplasmosis), Plasmodium spp. (malaria), and Cryptosporidium spp. (diarrheal diseases) as well as the veterinary pathogens Eimeria tenella (chicken coccidiosis) and Neospora caninum (neosporosis) [26]. T. gondii infects roughly 30% of the global human population [7]. While infection is typically asymptomatic in healthy individuals, infection in immunocompromised individuals can lead to fatal encephalitis [8,9]. In addition, congenital toxoplasmosis derived from a primary maternal infection can cause severe fetal abnormalities and abortion [10]. Existing treatments are restricted to limiting acute disease and are poorly tolerated [9]. Thus, a deeper understanding of the biology of this important pathogen is critically needed for the development of therapies based on parasite-specific activities.

The life cycles of apicomplexan parasites depend on a specialized organelle named the inner membrane complex (IMC), which plays critical roles in motility, host cell invasion, and parasite replication [11]. In T. gondii, the IMC lies directly underneath the parasite’s plasma membrane and is composed of two structures: a series of flattened vesicles called alveoli which are arranged in a quilt-like pattern and a supportive network of intermediate filament-like proteins called alveolins [12,13]. The IMC is further divided into distinct regions such as the cone-shaped apical cap at the apex of the parasite, a central body portion, and a ring-shaped basal complex at the basal end of the parasite. Detergent fractionation experiments have shown that IMC proteins can associate with the alveoli, the cytoskeletal network, or span between both layers [1416]. Additionally, IMC proteins differ by their presence in the maternal IMC, daughter IMC, or both [14,16]. Underlying the IMC is an array of 22 subpellicular microtubules that provide additional structural support for the organelle.

One of the key functions of the IMC is to facilitate parasite replication. Apicomplexans replicate using a variety of different budding mechanisms, all of which rely on the IMC to act as a scaffold for the developing daughter buds [17,18]. T. gondii replicates asexually by endodyogeny, a process of internal budding in which two daughter buds develop within the cytoplasm of a single maternal parasite. Budding is initiated upon centrosome duplication, which is quickly followed by the sequential recruitment of IMC proteins to the daughter cell scaffold (DCS) [14,1821]. As proteins are added to the DCS, polymerization of subpellicular microtubules underlying the daughter IMC drives elongation of the growing daughter buds [22,23]. In the final stages of bud maturation, the maternal IMC is degraded and the daughter cells adopt the maternal plasma membrane and emerge as two separate cells [11].

The synthesis and recruitment of IMC proteins to the DCS occurs in a “just in time” manner [24,25]. As such, IMC proteins can be categorized by their timing of recruitment. During bud initiation the daughter IMC proteins IMC29, IMC32, FBXO1, BCC0, and IMC15 are recruited to the DCS [14,2629]. IMC32 and BCC0 have been shown to be essential for parasite replication and survival, as their loss leads to an inability to stably assemble the IMC [27,28]. IMC29 and FBXO1, while not essential, also play critical roles in supporting the organization and maturation of the daughter IMC during endodyogeny [26,29]. The essential apical cap proteins AC9 and AC10 also localize to the daughter IMC during bud initiation, but these proteins are maintained in the maternal IMC and are involved in host cell invasion, rather than replication [30,31]. After bud initiation is completed, additional proteins such as ISP1 and the alveolins are added sequentially to the growing buds [14,32]. Though many protein components of the DCS have recently been identified, the organization, regulation, and precise function of most of these proteins remain poorly understood.

In this study, we identified and functionally analyzed a novel IMC protein, IMC43. We determined that IMC43 localizes to the body of the daughter IMC and is recruited during bud initiation. Using an auxin-inducible degron (AID) approach, we conditionally depleted IMC43 and showed that loss of the protein results in severe morphological defects, dysregulation of endodyogeny, and loss of overall lytic ability. We then performed deletion analyses which established that the function of IMC43 is dependent on a small region towards the C-terminus of the protein. Next, we used IMC43 as bait in both a TurboID proximity labelling experiment and a yeast two-hybrid (Y2H) screen to identify candidate IMC43 binding partners and provide insight into the precise function of the protein. Two of these proteins, the essential daughter protein IMC32 and a hypothetical protein we named IMC44, were functionally analyzed in relation to IMC43. These experiments showed that IMC43 is required for the proper localization of both of its partners and that binding at the essential C-terminal region of IMC43 is responsible for these interactions. Overall, our work identifies IMC43 as a foundational component of the early daughter IMC and reveals the existence of an IMC43-IMC32 daughter bud assembly complex which is essential for parasite replication and survival.

Results

IMC43 is a component of the early daughter cell scaffold

We have previously conducted proximity labelling to identify novel IMC proteins. In one of these experiments in which we used IMC29 as bait, we identified the uncharacterized protein TGGT1_238895 [29]. TGGT1_238895 encodes a 1,653 amino acid hypothetical protein which contains no identifiable functional domains (Figs 1A and S1A) [33,34]. We selected TGGT1_238895 for further analysis because of its extremely low phenotype score of -5.41 in a genome-wide CRISPR/Cas9 screen for fitness-conferring genes and its cyclical expression profile, which is similar to IMC29 (Fig 1B) [24,35].

Fig 1. TGGT1_238895 localizes to the daughter IMC body and is recruited at the earliest stages of endodyogeny.

Fig 1

A) Gene model of TGGT1_238895 (IMC43) showing the endogenous 3xHA tag fused to the C-terminus for localization studies. B) The cell-cycle expression profile for TGGT1_238895 closely matches the cyclical pattern of the known daughter IMC protein IMC29. RMA = robust multi-array average [24]. C) IFA showing that TGGT1_238895 is undetectable in mature parasites. Magenta = anti-HA detecting TGGT1_2388953xHA, Green = anti-IMC6. D) IFA showing that TGGT1_238895 localizes to daughter buds and colocalizes with IMC6. Magenta = anti-HA detecting TGGT1_2388953xHA, Green = anti-IMC6. E) IFA of budding parasites showing that TGGT1_238895 is excluded from the apical cap, marked by ISP1. Magenta = anti-HA detecting TGGT1_2388953xHA, Green = anti-ISP1. F) IFA showing that IMC43 recruits to the daughter IMC before IMC6. Magenta = anti-HA detecting IMC433xHA, Green = anti-IMC6. G) IFA showing that IMC43 recruits to the daughter IMC before ISP1. Arrow points to the mother cell apical cap. Asterisk indicates daughter buds. Magenta = anti-HA detecting IMC433xHA, Green = anti-ISP1. H) IFA showing that IMC43 recruits to the daughter IMC at the same time as FBXO1. Magenta = anti-Ty detecting IMC432xStrep3xTy, Green = anti-HA detecting FBXO13xHA. I) IFA showing that IMC43 recruits to the daughter IMC at the same time as AC10. Magenta = anti-HA detecting IMC433xHA, Green = anti-Ty detecting AC102xStrep3xTy. J) IFA showing that IMC43 recruits to the daughter IMC at the same time as IMC32. Magenta = anti-HA detecting IMC433xHA, Green = anti-V5 detecting IMC323xV5. Scale bars = 2 μm.

To determine the localization of TGGT1_238895, we endogenously tagged it with a C-terminal 3xHA epitope tag. The protein was undetectable by immunofluorescence assay (IFA) in mature parasites, but colocalized with the IMC body-localizing alveolin IMC6 in developing daughter buds (Fig 1C and 1D). To determine whether TGGT1_238895 localized to the daughter apical cap, we co-stained with the apical cap marker ISP1. TGGT1_238895 was found to be absent from the apical cap, indicating that it is exclusively an IMC body protein (Fig 1E). Based on its localization, we named the protein IMC43. To determine how early IMC43 is incorporated into developing daughter buds, we co-stained for other early daughter markers that have been previously studied. These experiments showed that IMC43 recruits to early daughters before IMC6 and ISP1 and around the same time as FBXO1, AC10, and IMC32 (Fig 1F–1J). From these data we concluded that IMC43 is a daughter-specific IMC body protein that is recruited to the DCS at the earliest stages of endodyogeny.

IMC43 is an essential protein involved in endodyogeny

Because IMC43 has a low phenotype score and is a component of the early daughter cell scaffold, we hypothesized that it was likely to play a critical role in parasite survival and replication [35]. We were unable to genetically disrupt IMC43, despite successful CRISPR/Cas9 targeting to its endogenous locus, indicating that IMC43 is likely essential as suggested by its phenotype score (S2 Fig). Thus, we used an auxin-inducible degron (AID) conditional knockdown system to study its function (Fig 2A) [36,37]. The degron-tagged protein (IMC43AID) localized correctly to the daughter IMC and was rapidly degraded upon treatment with indoleacetic acid (IAA) (Fig 2B). Western blot analysis confirmed efficient knockdown of the target protein (S3A Fig).

Fig 2. IMC43 is essential for parasite replication and survival.

Fig 2

A) Diagram showing the mAID-3xHA degron tag fused to the C-terminus of IMC43 in a TIR1-expressing strain to facilitate proteasomal degradation upon treatment with IAA. B) IFA showing that the IMC43AID protein localizes normally to the daughter IMC and is depleted when the parasites are treated with IAA. Magenta = anti-HA detecting IMC43AID, Green = anti-IMC6. C) IFA showing the broad range of morphological and replication defects observed after treating IMC43AID parasites with IAA for 24 hours. White arrows point to large gaps in the IMC marked by IMC6. Yellow arrows point to daughter buds present outside of the maternal parasite. Asterisks mark parasites producing more than two daughter buds. All three +IAA vacuoles also display desynchronized endodyogeny, where parasites in the same vacuole are at different stages of replication. Green = anti-IMC6. D) Quantification of vacuoles displaying morphological and/or replication defects after 24 hours of IMC43 depletion. Statistical significance was determined using a two-tailed t test (****, P < 0.0001). E) IFA of IMC43AID parasites treated with IAA for 40 hours. White arrows point to large gaps in the IMC marked by IMC6. Asterisks indicate swollen parasites. Green = anti-IMC6 F) Diagram of the full-length smOLLAS-tagged IMC43 complementation construct driven by its endogenous promoter (IMC43WT) and integrated at the UPRT locus in IMC43AID parasites. G) IFA showing that IMC43WT localizes normally to the daughter IMC and rescues the morphological and replication defects observed upon treatment with IAA. Magenta = anti-OLLAS detecting IMC43WT, Green = anti-IMC6. H) Plaque assays for IMC43AID and IMC43AID + IMC43WT parasites grown for seven days -/+ IAA. Depletion of IMC43 results in a severe defect in overall lytic ability, which is fully rescued by complementation with the wild-type protein. Scale bars = 0.5 mm. I) Quantification of plaque number for plaque assays shown in panel H. IMC43-depleted parasites form fewer than 10% as many plaques compared to control. Statistical significance was determined using multiple two-tailed t tests (****, P < 0.0001; ns = not significant). J) Quantification of plaque size for plaque assays shown in panel H. Plaques formed by IMC43-depleted parasites are <1% the usual size. Statistical significance was determined using multiple two-tailed t tests (****, P < 0.0001; ns = not significant). Scale bars for all IFAs = 2 μm.

To assess the effects of IMC43 knockdown on parasite morphology over the course of multiple replication cycles, parasites were treated with IAA for 24 hours and assessed by IFA (Fig 2C). IMC43-depleted parasites showed severe defects in IMC morphology, such as large gaps in the cytoskeleton marked by IMC6 and the presence of daughter buds that appeared to not be encased by the maternal IMC. IMC43-depleted parasites also exhibited a variety of replication defects, including asynchronous division and formation of more than two daughter buds per cell, indicating a severe dysregulation of endodyogeny. Quantification showed that 94.2% of vacuoles exhibited one or more of these issues after only 24 hours of IAA treatment (Fig 2D), with most vacuoles exhibiting multiple defects simultaneously. When we extended the IAA treatment to 40 hours, we saw continued growth despite these defects, which appeared to accumulate over time (Fig 2E). To confirm that these defects were due to the loss of IMC43, we generated a full-length IMC43 complementation construct driven by its endogenous promoter and integrated it at the UPRT locus (IMC43WT) (Figs 2F and S3B). Complementation with IMC43WT fully rescued the observed morphological and replication defects (Fig 2G).

To determine how loss of IMC43 affects the parasite’s overall lytic ability on a longer time course, we performed plaque assays (Fig 2H). IMC43-depleted parasites exhibited a severe defect in plaque efficiency, forming <10% as many plaques compared to vehicle-treated IMC43AID parasites (Fig 2I). The few plaques that they did form were also drastically smaller than normal: <1% the size of plaques formed by vehicle-treated parasites (Fig 2J). The defects in both plaque efficiency and plaque size were fully rescued by complementation with the wild-type protein. Since we were unable to generate a stable knockout line, it’s likely that these few small plaques are formed by a small percentage of parasites that experience incomplete knockdown.

To dissect the phenotype of IMC43-depleted parasites further, we co-stained for markers of key structures involved in endodyogeny. First, we stained for the daughter IMC body protein IMC29, which localized normally despite the gross morphological defects (Fig 3A). Next, we stained for the apical cap marker AC10, the basal complex marker MORN1, and tubulin. These experiments showed that the apical cap, basal complex, conoid, and subpellicular microtubules appear to assemble on nascent daughter buds in the absence of IMC43 (Fig 3B–3D). Finally, we stained for the centrosome marker Centrin1, as well as DNA marked by Hoechst staining. This showed that in the absence of IMC43, parasites continue nuclear division and centrosome duplication in an apparent attempt to continue replicating (Fig 3E and 3F). Together, these data indicate that IMC43 is an essential protein which is required for replication, structural integrity of the IMC, and parasite survival.

Fig 3. Assessment of key structures involved in endodyogeny.

Fig 3

A) IFA showing that the daughter IMC protein IMC29 is unaffected by depletion of IMC43. Magenta = anti-V5 detecting IMC293xV5, Green = anti-IMC6. B) IFA showing that the apical cap marker AC10 is unaffected by depletion of IMC43. Arrows point to the apical cap of daughter buds. Magenta = anti-V5 detecting AC103xV5, Green = anti-IMC6. C) IFA showing that the basal complex marker MORN1 is unaffected by depletion of IMC43. Arrows point to the basal complex of daughter buds. Magenta = anti-V5 detecting MORN13xV5, Green = anti-IMC6. D) IFA showing that the conoid and subpellicular microtubules still assemble on nascent daughter buds when IMC43 is depleted. Arrows point to daughter bud conoids. Magenta = transiently expressed Tubulin1-GFP, Green anti-IMC6. E) IFA showing that centrosome duplication continues when IMC43 is depleted. Centrosomes, marked by Centrin1, appear to duplicate and associate with daughter buds and dividing nuclei. Parasites forming more than two daughter buds also form more than two centrosomes. White arrow points to a single parasite containing two centrosomes (normal). Yellow arrows point to single parasites containing three or more centrosomes (abnormal). Magenta = anti-Centrin1, Green = anti-IMC1, Blue = Hoechst. F) IFA showing that nuclear division and centrosome duplication continue after 40 hours of IAA treatment. Magenta = anti-Centrin1, Green = anti-IMC1, Blue = Hoechst. Scale bars = 2 μm.

IMC43 contains an essential functional domain near the C-terminus of the protein

Like many other IMC proteins, IMC43 lacks homology to known proteins and has no readily identifiable functional domains. To dissect which regions of the protein are important for localization and function, we developed a series of nine deletion constructs guided by predicted secondary structure and conservation with N. caninum (Figs 4A and S1B) [38]. Each deletion construct was integrated into the UPRT locus in the IMC43AID strain, as we did previously for IMC43WT. Western blot analysis confirmed that each of the deletion constructs was expressed at similar levels to IMC43WT and ran at approximately the expected size (S3C Fig). Eight of the nine deletion constructs colocalized completely with the wild-type protein (S4 Fig). The only deletion construct which did not was IMC43Δ402–494, which enriched at daughter buds but also partially mistargeted to the cytoplasm (Fig 4B). Surprisingly, almost all the deletion constructs were also able to rescue both the morphological and replication defects. The only exception was the Δ1441–1653 mutant, a C-terminal truncation of the protein (Fig 4C and 4D, S5). To narrow down the essential region of the C-terminus, we constructed two smaller sub-deletions: Δ1441–1561 and Δ1562–1653. The Δ1562–1653 mutant fully rescued the phenotype of the knockdown, while the Δ1441–1561 mutant did not, indicating that residues 1441–1561 are essential for the function of IMC43 (Figs 4E–4G and S3D).

Fig 4. Deletion analyses reveal regions involved in IMC43 localization and function.

Fig 4

A) Diagram of the nine deletion constructs generated for domain analysis of IMC43. B) IFA showing the localization of IMC43Δ402–494 compared to IMC43AID. IMC43Δ402–494 partially mislocalizes to the cytoplasm of parasites (arrow). Magenta = anti-OLLAS detecting IMC43Δ402–494, Green = anti-HA detecting IMC43AID. C) IFA showing that IMC43Δ1441–1653 fails to rescue the morphological and replication defects caused by depletion of endogenous IMC43. Arrow points to a single maternal parasite producing five daughter buds, indicating dysregulation of endodyogeny. Asterisks indicate disruption of the cytoskeleton. Magenta = anti-OLLAS detecting IMC43Δ1441–1653, Green = anti-IMC6. D) Quantification of plaque number for IMC43AID, IMC43AID + IMC43WT, and all nine IMC43 deletion strains shown in panel A after seven days of growth -/+ IAA. Y axis represents the number of plaques formed in +IAA conditions divided by the number of plaques formed in -IAA conditions for each strain. Statistical significance was determined by one-way ANOVA (****, P < 0.0001; ns = not significant). E) IFA showing that IMC43Δ1441–1561 fails to rescue the morphological and replication defects caused by depletion of endogenous IMC43. Arrow points to a single maternal parasite producing three daughter buds, indicating dysregulation of endodyogeny. Asterisks indicate disruption of the cytoskeleton. Magenta = anti-OLLAS detecting IMC43Δ1441–1561, Green = anti-IMC6. F) IFA showing that IMC43Δ1562–1653 rescues the morphological and replication defects caused by depletion of endogenous IMC43. Magenta = anti-OLLAS detecting IMC43Δ1562–1653, Green = anti-IMC6. G) Quantification of plaque number for IMC43AID, IMC43AID + IMC43WT, IMC43AID + IMC43Δ1441–1561, and IMC43AID + IMC43Δ1562–1653 parasites after seven days of growth -/+ IAA. Y axis represents the number of plaques formed in +IAA conditions divided by the number of plaques formed in -IAA conditions for each strain. Statistical significance was determined by one-way ANOVA (****, P < 0.0001; ns = not significant). Scale bars = 2 μm.

Identification of IMC43 binding partners using TurboID and Y2H screening

To further investigate IMC43, we used both TurboID proximity labelling and a yeast two-hybrid (Y2H) screen to identify candidate binding partners [3941]. For the TurboID experiment, we fused the TurboID biotin ligase plus a 3xHA tag to the C-terminus of IMC43 (Fig 5A). IMC43TurboID localized normally and robustly biotinylated the daughter IMC when treated with biotin, confirming that the TurboID biotin ligase is enzymatically active (Fig 5B). Therefore, we continued with a large-scale TurboID experiment and analyzed the results by mass spectrometry. The results were filtered to include only genes that were at least two-fold enriched with a difference of >5 spectral counts when comparing the IMC43TurboID sample to the control sample (S1 Table). For the Y2H screen, we used Hybrigenics Services to screen against the T. gondii RH strain cDNA library using the full-length IMC43 protein as the bait. We included any hits that were assigned a confidence score of “A” (very high), “B” (high), “C” (good), or “D” (moderate) in our analysis (S2 Table). A total of 30 proteins were identified using both approaches (Fig 5C and 5D). To prioritize proteins for further analysis, we considered their enrichment in the TurboID experiment, confidence score in the Y2H screen, transcriptional profile throughout the cell cycle, and known or predicted association with the daughter IMC [24,42]. Based on these criteria we selected two candidate IMC43 binding partners to explore further: the essential daughter protein IMC32 and the hypothetical protein encoded by TGGT1_297120.

Fig 5. TurboID and Y2H screens yield 30 candidate IMC43 binding partners.

Fig 5

A) Diagram of IMC43TurboID. B) IFA showing that IMC43TurboID localizes normally to the daughter IMC and biotinylates proximal proteins in a biotin-dependent manner. Arrows point to endogenously biotinylated apicoplasts. Magenta = anti-HA detecting IMC43TurboID, Green = streptavidin. Scale bars = 2 μm. C) Venn diagram comparing genes identified in the Y2H screen and TurboID experiments. All Y2H hits that were ranked as “D” (moderate confidence) or higher were included. TurboID results were filtered to include only genes that were at least two-fold enriched with a difference of >5 spectral counts when comparing IMC43TurboID to control. 30 genes were identified in both experiments after filtering results as described. D) Table showing the 30 genes identified in both the TurboID and Y2H screens. The two candidate binding partners analyzed in this study are highlighted in yellow. “Y2H” column indicates the confidence score assigned in the Y2H screen (B = high confidence, C = good confidence, D = moderate confidence). “TurboID Ctrl / Exp” column indicates the average spectral count for each gene in the control and IMC43TurboID mass spectrometry results. “GWCS” refers to the phenotype score assigned to each gene in a genome-wide CRISPR/Cas9 screen [35]. “Localization” column reports the known localization of each protein [13,15,16,27,29,4850,5456,76]. Localizations followed by “(LOPIT)” indicate predicted localizations based on hyperplexed localization of organelle proteins by isotope tagging (hyperLOPIT) [42].

TGGT1_297120 encodes a novel IMC protein with a dynamic localization that is dependent on IMC43

TGGT1_297120 was designated as a “B” hit in our Y2H screen and was highly enriched in our IMC43TurboID results (Figs 5D and 6A). It also exhibits a cyclical transcriptional profile throughout the cell cycle, closely mirroring that of IMC43 (Fig 6B) [24]. Endogenous tagging of the gene in our IMC43AID parasites revealed that the protein is absent from mature parasites and exhibits a dynamic localization pattern in the IMC of daughter buds. At bud initiation, TGGT1_297120 appears in a small ring shape, similar to IMC43. During early budding, the protein appears to be restricted to the body of the daughter IMC. As the daughter buds expand, TGGT1_297120 maintains its localization in the body of the IMC and additionally becomes enriched in the basal complex. Finally, during late endodyogeny and bud maturation, the protein shifts completely to the basal complex, where it localizes just adjacent to MORN1, and finally disappears once the buds emerge as mature cells (Fig 6C and 6D). Given the dynamic localization of TGGT1_297120 within the daughter IMC, we named the protein IMC44.

Fig 6. IMC44 is a novel IMC protein which depends on IMC43 binding for regulation of its dynamic localization.

Fig 6

A) Gene model of TGGT1_297120 (IMC44) showing the region determined to interact with IMC43 by the Y2H screen. B) The cell-cycle expression profile for TGGT1_297120 closely mirrors the cyclical pattern of IMC43. RMA = robust multi-array average [24]. C) IFAs showing the localization of TGGT1_297120 at different stages of endodyogeny. Arrows indicate the point at which TGGT1_297120 can be first seen localizing to the basal complex of daughter buds. Magenta = anti-Myc detecting TGGT1_2971203xMyc, Green = anti-IMC6. D) IFAs comparing the localization of TGGT1_297120 with the basal complex marker MORN1. Arrows point to the basal complex of daughter buds. Magenta = anti-Myc detecting TGGT1_2971203xMyc, Green = anti-V5 detecting MORN13xV5. E) IFA showing the localization of IMC44 in IMC43AID parasites -/+ IAA. Depletion of IMC43 causes IMC44 to fail to localize to the body of the IMC. Arrows point to the body of the IMC in daughter buds. Magenta = anti-Myc detecting IMC443xMyc, Green = anti-IMC6. F) IFA showing the localization of IMC44 in IMC43AID + IMC43WT parasites -/+ IAA. IMC43WT rescues the mislocalization of IMC44 observed in IMC43-depleted parasites. Arrows point to the body of the IMC in daughter buds. Magenta = anti-Myc detecting IMC443xMyc, Green = anti-IMC6. G) IFA showing the localization of IMC44 in IMC43AID + IMC43Δ1441–1561 parasites -/+ IAA. IMC43Δ1441–1561 fails to rescue the mislocalization of IMC44 observed in IMC43-depleted parasites. Arrows point to the body of the IMC in daughter buds. Magenta = anti-Myc detecting IMC443xMyc, Green = anti-IMC6. Scale bars = 2 μm. H) Diagrams showing the fragments of IMC43 and IMC44 that were fused to LexA/GAL4AD for pairwise Y2H assays. I) Pairwise Y2H assays assessing the interaction of IMC43 and IMC44. Growth on restrictive (-L/W/H) media indicates binding between the indicated fragments of each protein.

To explore the function of IMC44, we used CRISPR/Cas9 to disrupt its gene, which was confirmed by IFA and PCR (S6A and S6B Fig). The Δimc44 parasites did not have any gross morphological defects (S6A Fig). Plaque assays showed that loss of IMC44 had no effect on overall lytic ability, as expected based on its modest phenotype score (S6C and S6D Fig). We next endogenously tagged IMC43 in the Δimc44 parasite line. IFA showed that the localization of IMC43 was unaffected in the Δimc44 parasites, indicating that IMC43 localizes independently of its partner IMC44 (S6E Fig). Together, these data indicate that IMC44 is dispensable for parasite fitness and does not play a role in IMC43 localization.

We next wanted to assess how depletion of IMC43 affects the localization of IMC44. When IMC43 was depleted, IMC44 failed to localize to the body of the IMC during the early stages of endodyogeny and instead localized to the basal complex (Fig 6E). Normal IMC44 localization was restored when we complemented with IMC43WT, confirming that this change in localization was due to the loss of IMC43 (Fig 6F). To determine if this mislocalization could be linked to a specific region of IMC43, we endogenously tagged IMC44 in each of our ten IMC43 deletion constructs and used IFA to assess whether each deletion could rescue the mislocalization of IMC44 in the presence of IAA. Only the Δ1441–1561 mutant failed to rescue the mislocalization of IMC44, indicating that the essential region of IMC43 plays a role in the localization of IMC44 (Figs 6G and S7). To determine whether this region is directly involved in binding to IMC44, we used pairwise Y2H assays. Fragments of IMC43 and IMC44 were cloned into Y2H bait and prey vectors, co-transformed into yeast, and spotted on permissive (-L/W) and restrictive (-L/W/H) media to assess binding. These experiments demonstrated that the C-terminus of IMC43, which contains the essential domain, is sufficient for binding to IMC44 at either its N-terminus or its C-terminus (Fig 6H and 6I). Together these data indicate that the essential C-terminal domain of IMC43 binds to IMC44 and regulates its localization during endodyogeny.

IMC43 regulates the organization of IMC32 in the daughter cell scaffold

The second candidate IMC43 binding partner we explored was IMC32, a daughter-enriched IMC body protein that we previously showed is essential for parasite replication and survival [27]. IMC32 contains five coiled-coil (CC) domains at its C-terminus, which we previously determined to be necessary for both its localization and function [27]. We also recently discovered a domain in the center of the protein which has structural homology to the fused Ig-PH domain from the plant actin-binding protein SCAB1 (Fig 7A). IMC32 was identified as a “D” hit in our Y2H screen and was also relatively low abundance in our TurboID mass spectrometry results (Fig 5D). However, its localization, timing of recruitment, and function are all very similar to IMC43. Additionally, our Y2H screen data determined that three of the essential CC domains of IMC32 are involved in binding to IMC43, further supporting that IMC32 may be a true binding partner of IMC43 (Fig 7A).

Fig 7. IMC43 binding is required for maintenance of IMC32 during later stages of endodyogeny.

Fig 7

A) Gene model of IMC32 showing its predicted N-terminal palmitoylation site, Ig-PH domain, 5 predicted CC domains, and IMC43-interacting region identified by the Y2H screen. B) IFA comparing the localization of IMC43 and IMC32 at the mid/late budding stages of endodyogeny. Top: Daughter buds viewed from the side. Bottom: Daughter buds viewed from below. Magenta = anti-V5 detecting IMC323xV5, Green = anti-HA detecting IMC43AID. C) IFA showing the localization of IMC32 during bud initiation in IMC43AID parasites after 18 hours of growth -/+ IAA. Depletion of IMC43 has no effect on IMC32 localization during bud initiation. Magenta = anti-V5 detecting IMC323xV5, Green = anti-IMC6. D) IFA showing the localization of IMC32 during the late-budding stage in IMC43AID parasites after 18 hours of growth -/+ IAA. Depletion of IMC43 causes IMC32 to lose its characteristic striped localization pattern at this stage of endodyogeny. Magenta = anti-V5 detecting IMC323xV5, Green = anti-IMC6. E) IFA showing the localization of IMC32 in IMC43AID parasites after 30 hours of growth -/+ IAA. Depletion of IMC43 over a longer time course results in an accumulation of mislocalized IMC32 in the cytoplasm. White arrows point to IMC32 enriching at early daughter buds. Yellow arrows point to daughter buds at the mid/late-budding stage with diffuse and disorganized IMC32 staining. Magenta = anti-V5 detecting IMC323xV5, Green = anti-IMC6. F) IFA showing the localization of IMC32 in IMC43AID + IMC43WT parasites after 18 hours of growth -/+ IAA. IMC43WT rescues the mislocalization of IMC32 caused by depletion of IMC43. Magenta = anti-V5 detecting IMC323xV5, Green = anti-IMC6. G) Quantification of vacuoles with mislocalized IMC32 at different stages of endodyogeny after 18 hours of growth -/+ IAA. Approximately 76% of vacuoles at the mid and late budding stages exhibited mislocalization of IMC32 when IMC43 was depleted. This phenotype was fully rescued by complementation with IMC43WT. Statistical significance was determined using multiple two-tailed t tests (****, P < 0.0001; ns = not significant). H) IFA showing the localization of IMC32 in IMC43AID + IMC43Δ1441–1561 parasites after 24 hours of growth -/+ IAA. IMC43Δ1441–1561 fails to rescue the mislocalization of IMC32 caused by depletion of IMC43. Magenta = anti-V5 detecting IMC323xV5, Green = anti-IMC6. Scale bars = 2 μm. I) Diagrams showing the fragments of IMC43 and IMC32 that were fused to LexA/GAL4AD for pairwise Y2H assays. J) Pairwise Y2H assays assessing the interaction of IMC43 and IMC32. Growth on restrictive (-L/W/H) media indicates binding between the indicated fragments of each protein.

To investigate the relationship between IMC32 and IMC43, we endogenously tagged IMC32 in our IMC43AID line. As we previously reported, IMC32 localizes to five distinct puncta arranged in a pentagon during bud initiation. As the buds elongate, IMC32 extends into a series of five longitudinal stripes that stretch along the body of the daughter IMC (Fig 7B) [27]. When we examined IMC32 localization in IMC43-depleted parasites, we found that IMC32 exhibited normal localization during the bud initiation and early budding stages (Fig 7C). However, during mid- and late-budding, IMC32 became disorganized. The usual pattern of stripes along the body of the IMC was frequently missing, and instead, IMC32 had a diffuse staining pattern in the body of the daughter IMC and in the cytoplasm (Fig 7D). Accumulation of these defects during a longer IAA treatment led to increased cytoplasmic mislocalization (Fig 7E). Quantification showed that IMC32 was mislocalized in approximately 78% of vacuoles containing parasites at the mid- and late-budding stages when IMC43 was depleted. This defect was fully rescued by complementation with IMC43WT (Fig 7F and 7G). This indicates that while IMC32 initially recruits to the DCS independently of IMC43, its’ organization during later stages of endodyogeny is dependent on IMC43.

To determine whether IMC43 relies on IMC32 for its localization as well, we generated an IMC32AID line in which IMC43 is endogenously tagged (S8A Fig). IFA showed efficient depletion of IMC32 resulting in severe morphological and replication defects as we have previously reported using an anhydrotetracycline transactivator-based regulation system (S8B Fig) [27]. IMC32 depletion had no effect on the localization of IMC43, indicating that IMC43 localizes independently of IMC32 (S8C Fig).

Next, we wanted to determine which region of IMC43 is required for the proper organization of IMC32 in the DCS. To assess this, we endogenously tagged IMC32 in each of our ten IMC43 deletion lines and used IFA to determine whether each deletion could rescue the mislocalization of IMC32. The Δ1441–1561 mutant was the only one that failed to rescue the mislocalization of IMC32, indicating that the essential region of IMC43 is involved in regulating the localization of IMC32 (Figs 7H and S9). To directly assess the binding interaction between IMC43 and IMC32, we once again used pairwise Y2H assays. These experiments demonstrated that the C-terminus of IMC43 is sufficient for binding to IMC32’s CC domains (Fig 7I and 7J). Together, these data indicate that the essential C-terminal domain of IMC43 binds to IMC32’s CC domains and controls its localization during the middle and late stages of endodyogeny.

Discussion

In this study, we identified and characterized IMC43 as a novel daughter-specific IMC protein which plays an essential role in endodyogeny. We also used proximity labelling and Y2H approaches to identify and explore its binding partners. Our data demonstrates that depletion of IMC43 results in severe morphological and replication defects, resulting in a loss of overall lytic ability. The phenotype of IMC43-depleted parasites closely resembles that of IMC32-depleted parasites [27]. Loss of both proteins results in cytoskeletal instability, swelling, asynchronous division, formation of more than two daughter buds per cell, and excessive rounds of nuclear division and centrosome duplication (Fig 8A) [27]. The observed morphological defects are also similar to that observed for BCC0 [28]. One key difference between IMC43 and BCC0 is that loss of BCC0 was reported to cause a partial disruption of the basal complex in daughter buds, whereas we demonstrated that the basal complex is unaffected by loss of IMC43. Finally, the severe replication defects are also similar to Δimc29 parasites, although these defects are observed at a higher frequency in IMC43-depleted parasites [29].

Fig 8. Summary.

Fig 8

A) Diagram summarizing the effects of IMC43 depletion. Depletion of IMC43 causes gross morphological defects such as swelling, cytoskeletal instability, asynchronous division, excess budding & nuclear division, and loss of overall lytic ability. Assembly of the basal complex and apical cap remain unaffected. B) Diagram summarizing the relationship between IMC43 and its binding partners IMC32 and IMC44. The newly identified Localization domain (LOC) and Essential Interaction Domain (EID) of IMC43 are shown. Grey boxes indicate interactions between the Essential Interaction Domain of IMC43 and IMC32/IMC44. Boxed panels include a diagram showing how depletion of IMC43 affects the localization of IMC32 and IMC44 throughout bud initiation (1), early/mid-budding (2), and late budding (3).

While IMC43 does not contain any functional domains identifiable by sequence or structural homology, our deletion analyses identified two important regions. We first identified a small region towards the N-terminus (residues 402–494) which plays a minor role in localization of the protein. Deletion of this region led to a partial mislocalization of the protein to the cytoplasm. While this partial mislocalization could be due to protein misfolding, the fact that the Δ402–494 mutant rescues the phenotype of the knockdown makes this less likely. Furthermore, this region of the protein is more conserved than nearby regions, supporting the hypothesis that this region may contain a domain involved in localization. Given these data, we tentatively assign the region encompassed by residues 402–494 as the Localization Domain (LOC) (Fig 8B). However, since none of the deletions fully abolished targeting to the IMC, other regions of the protein must play a role in localization. We also identified a domain near the C-terminus of the protein which is essential for the function of IMC43. This region is highly conserved and is one of the few regions of the protein that is not predicted to be intrinsically disordered [43]. AlphaFold predicts a four-helix bundle in this region, although the confidence is relatively weak [33,44,45]. Four-helix bundles are structurally similar to coiled-coils which often play roles in protein-protein interactions [46,47]. Based on its essential function in facilitating interaction between IMC43 and its partners, we named this region the Essential Interaction Domain (EID) (Fig 8B).

By combining the results of TurboID proximity labelling and a Y2H screen, we identified 30 candidate IMC43 binding partners and investigated two of them in relation to IMC43. This led us to two key findings: the identification of IMC44 as a novel daughter IMC protein with a dynamic localization which is dependent on IMC43, and the discovery of an essential IMC43-IMC32 daughter bud assembly complex that is critical for endodyogeny. IMC44 was found to have a dynamic localization pattern in which it localizes to the body of the IMC during the early stages of endodyogeny and then transitions to the basal complex during the middle and late stages. A similar dynamic localization has previously been reported for the alveolins IMC5, -8, -9, and -13, and also for the recently discovered BCC3 [14,28]. IMC44’s localization within the IMC body is similar to the alveolins, whereas BCC3 appears to be present in the sutures of the daughter bud. However, the timing of IMC44’s shift to the basal complex is more like that of BCC3, which also begins to transition to the basal complex during mid-budding, rather than just prior to bud constriction like the alveolins. Interestingly, all five of these proteins, as well as IMC44, have moderate fitness scores, and we showed here that IMC44 is dispensable [35]. Given their shared localization patterns, it’s possible that there may be some functional redundancy among these proteins that explains their dispensability. For IMC44, we found that localization to the IMC body is dependent on IMC43, while localization to the basal complex occurs independent of IMC43. It’s possible that IMC44’s localization to the basal complex relies instead on binding to another basal complex-localizing protein. Since IMC5, -8, -9, and -13 shift to the basal complex later than IMC44, it will be interesting to see whether disruption of IMC44 affects any of their localizations.

The identification of IMC32 as an IMC43 binding partner was exciting due to their similar essential functions in endodyogeny. Intriguingly, we found that while IMC32 can localize to the early DCS during bud initiation independently, the maintenance of its striped localization pattern during mid and late budding requires IMC43. We also demonstrated that the C-terminus of IMC43 is sufficient for binding to IMC32’s C-terminal CC domains (Fig 8B). In our previous study, we showed that the localization of IMC32 requires both its predicted N-terminal palmitoylation site and at least one of its C-terminal CC domains [27]. This suggests a model in which IMC32 initially recruits to the DCS via palmitoylation and is maintained in the later stages of endodyogeny by binding to IMC43. Together, our data indicates that IMC43 and IMC32 make up an essential protein complex in the DCS and are required for proper progression of endodyogeny. However, it is somewhat puzzling that IMC32 appears to be conserved throughout the Apicomplexa, whereas clear orthologs of IMC43 are only found in N. caninum, Hammondia hammondi, and Besnoitia besnoiti [27]. One possibility is that an ortholog of IMC43 is present in other apicomplexans but has diverged so much that it’s no longer recognizable by sequence homology. This hypothesis is supported by the fact that the 43 kDa Sarcocystic neurona protein encoded by SN3_03500255 and the 62 kDa Cystoisospora suis protein encoded by CSUI_009138 have significant homology to the essential C-terminus of IMC43. Alternatively, it is possible that IMC32 evolved to localize independently of other proteins in other apicomplexan parasites or relies on a different binding partner. Investigating the function of IMC32 in Plasmodium spp. would provide more insight into this question.

Of the remaining 28 candidate IMC43 binding partners, 25 were identified as “D” hits in the Y2H screen. “D” hits indicate moderate confidence in the interaction and represent a mix of false-positives and genuine interactions that are difficult to detect by Y2H due to low mRNA abundance in the T. gondii library, difficulty folding in yeast, or toxicity when expressed in yeast [40,41]. Given this caveat, it’s important to directly interrogate each candidate to determine whether it’s likely to be a bona fide binding partner. One example of this is IMC32, which was scored as a D hit and was validated in this study as a true partner of IMC43. It’s likely that IMC32 had a moderate confidence score due to low mRNA abundance in the T. gondii library, which was produced using extracellular (non-budding) parasites. Other D hits include several proteins which are known to localize to daughter buds, including IMC30, IMC31, IMC34, PHIL1, IMC1, and TGGT1_246720 [13,29,4850]. Given their shared localization with IMC43, these proteins represent interesting targets for future studies.

Another interesting finding from our interaction screening experiments was the identification of three kinases and one phosphatase as candidate IMC43 binding partners. Phosphoproteomics studies have identified several phosphorylation sites in IMC43, raising the possibility that phosphorylation could be important for the regulation of IMC43 localization or function. The putative cell-cycle-associated protein kinase SRPK was identified as a B hit and was found to bind via its kinase domain to IMC43 [51]. Similarly, the kelch repeat domain-containing serine/threonine protein phosphatase protein PPKL was identified as a “C” hit and was found to bind to IMC43 at two locations: its phosphatase domain and a region just N-terminal to the kelch repeat domain [52]. The fact that IMC43 binds to these proteins at their active sites suggests that IMC43 could be a substrate of SRPK and/or PPKL. SRPK has not been studied in T. gondii, but its low phenotype score suggests an essential function [35]. In P. falciparum, PPKL has been shown to be crucial for ookinete development and microtubule tethering to the IMC, and a recent pre-print by Yang et al. demonstrated that it plays an essential role in regulating daughter bud formation in T. gondii [53,54]. Additionally, both the aurora kinase Ark3 and the calcium-dependent protein kinase CDPK7 were identified as “D” hits and were previously shown to be involved in parasite replication [55,56]. Neither protein was found to bind to IMC43 at their kinase domain, so they are less likely to phosphorylate IMC43. However, IMC43 could still bind to these proteins to regulate their localization or activity. Exploring these candidate interactors and determining how their activity affects the function of IMC43 will be a fascinating topic of future studies.

Together, the data presented in this study identifies IMC43 as a foundational protein involved in T. gondii endodyogeny and reveals the existence of an essential IMC43-IMC32 daughter bud assembly complex. The protein-protein interaction data presented in this study yields ample opportunities for future studies that will inform our knowledge of how daughter IMC assembly is regulated. Furthering our understanding of this process will be vital for the identification of novel drug and vaccine targets for diseases caused by apicomplexan parasites.

Materials and methods

T. gondii and host cell culture

Parental T. gondii RHΔhxgprtΔku80 (wild-type) and subsequent strains were grown on confluent monolayers of human foreskin fibroblasts (BJ, ATCC, Manassas, VA) at 37°C and 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 5% fetal bovine serum (Gibco), 5% Cosmic calf serum (Hyclone), and 1x penicillin-streptomycin-L-glutamine (Gibco). Constructs containing selectable markers were selected using 1 μM pyrimethamine (dihydrofolate reductase-thymidylate synthase [DHFR-TS]), 50 μg/mL mycophenolic acid-xanthine (HXGPRT), or 40 μM chloramphenicol (CAT) [5759]. Homologous recombination to the UPRT locus was negatively selected using 5 μM 5-fluorodeoxyuridine (FUDR) [60].

Antibodies

The HA epitope was detected with mouse monoclonal antibody (mAb) HA.11 (BioLegend; 901515) and rabbit polyclonal antibody (pAb) anti-HA (Invitrogen; PI715500). The Ty1 epitope was detected with mouse mAb BB2 [61]. The c-Myc epitope was detected with mouse mAb 9E10 [62]. The V5 epitope was detected with mouse mAb anti-V5 (Invitrogen; R96025) and rabbit mAb anti-V5 (Cell Signaling Technology; 13202S). The OLLAS epitope was detected with rat mAb anti-OLLAS [63]. Toxoplasma-specific antibodies include rabbit pAb anti-IMC6 [64], mouse mAb anti-IMC1 [65], mouse mAb anti-ISP1 [32], rabbit pAb anti-Centrin1 (Kerafast; EBC004) [66], and rabbit anti-Catalase [67].

Endogenous epitope tagging and knockout

For C-terminal endogenous tagging, a pU6-Universal plasmid containing a protospacer against the 3′ untranslated region (UTR) of the target protein approximately 100 bp downstream of the stop codon was generated, as described previously [68]. A homology-directed repair (HDR) template was PCR amplified using the Δku80-dependent LIC vector pmAID3xHA.LIC-HXGPRT, pmAID3xTy.LIC-HXGPRT, p3xHA.LIC-DHFR, p3xMyc.LIC-DHFR, p2xStrep3xTy.LIC-CAT, p2xStrep3xTy.LIC-HXGPRT, p3xV5.LIC-DHFR, p3xV5.LIC-HXGPRT, psmOLLAS.LIC-DHFR, or pTurboID3xHA.LIC-DHFR, all of which include the epitope tag, 3′ UTR, and a selection cassette [69]. The 60-bp primers include 40 bp of homology immediately upstream of the stop codon or 40 bp of homology within the 3′ UTR downstream of the CRISPR/Cas9 cut site. Primers that were used for the pU6-Universal plasmid as well as the HDR template are listed in S3 Table.

For N-terminal endogenous tagging of MORN1, a synthetic gene containing 146 bp of homology upstream of the start codon, a 3xV5 tag, and 219 bp of homology downstream of the start codon (primer P55) was ligated into a pJet vector (MORN1.3xV5.pJet). A homology-directed repair (HDR) template was PCR amplified from the MORN1.3xV5.pJet vector using primers P58 and P59. The protospacer was designed to target the sequence just downstream of the MORN1 start codon and was ligated into the pU6-Universal plasmid.

For knockout of IMC43 and IMC44, the protospacer was designed to target the coding region of the gene of interest, ligated into the pU6-Universal plasmid and prepared similarly to the endogenous tagging constructs. The HDR template was PCR amplified from a pJET vector containing the HXGPRT drug marker driven by the NcGRA7 promoter using primers that included 40 bp of homology immediately upstream of the start codon or 40 bp of homology downstream of the region used for homologous recombination for endogenous tagging.

For all tagging and knockout constructs, approximately 50 μg of the sequence-verified pU6-Universal plasmid and the PCR-amplified HDR template were electroporated into the appropriate parasite strain. Transfected cells were allowed to invade a confluent monolayer of HFFs overnight, and appropriate selection was applied. Successful tagging was confirmed by IFA, and clonal lines of tagged parasites were obtained through limiting dilution.

Complementation of IMC43AID parasites

The IMC43 coding region was PCR amplified from cDNA using primers P9 and P10. This was cloned into pUPRTKO-IMC32HA [27] using BglII/NotI to make pUPRTKO-IMC32p-IMC43-3xHA. Next, the endogenous promoter (EP) was amplified from genomic DNA using primers P11 and P12 and the entire pUPRTKO-IMC32p-IMC43-3xHA plasmid except for the IMC32 promoter was amplified using primer P13 and P14. The two fragments were then ligated using Gibson Assembly to make pUPRTKO-EP-IMC43-3xHA (E2611, NEB). Finally, an smOLLAS tag was amplified from the p-smOLLAS-DHFR-LIC vector using primers P15 and P16 and the entire pUPRTKO-EP-IMC43-3xHA plasmid except for the 3xHA tag was amplified using primers P17 and P18. The two fragments were then ligated using Gibson assembly to make pUPRTKO-EP-IMC43WT-smOLLAS (IMC43WT). This complement vector was then linearized with PsiI-HFv2 and transfected into IMC43AID parasites along with a pU6 that targets the UPRT coding region. Selection was performed with 5 μg/mL 5-fluorodeoxyuridine (FUDR) for replacement of UPRT. Clones were screened by IFA, and an smOLLAS-positive clone was designated IMC43WT. IMC43WT was used as the template to generate deletion constructs using Q5 site-directed mutagenesis with primers P19-P38 (E0552S, NEB). The same processes for linearization, transfection, and selection were followed for all deletion and mutant constructs. All restriction enzymes were purchased from NEB.

Immunofluorescence assay

Confluent HFF cells were grown on glass coverslips and infected with T. gondii. After 18–40 hours, the coverslips were fixed with 3.7% formaldehyde in PBS and processed for immunofluorescence as described [70]. Primary antibodies were detected by species-specific secondary antibodies conjugated to Alexa Fluor 594/488/405 (ThermoFisher). Coverslips were mounted in Vectashield (Vector Labs), viewed with an Axio Imager.Z1 fluorescent microscope and processed with ZEN 2.3 software (Zeiss).

Western blot

Parasites were lysed in 1x Laemmli sample buffer with 100 mM DTT and boiled at 100°C for 5 minutes. Lysates were resolved by SDS-PAGE and transferred to nitrocellulose membranes, and proteins were detected with the appropriate primary antibody and corresponding secondary antibody conjugated to horseradish peroxidase. Chemiluminescence was induced using the SuperSignal West Pico substrate (Pierce) and imaged on a ChemiDoc XRS+ (Bio-Rad).

Plaque assay

HFF monolayers were infected with 200 parasites/well of individual strains and allowed to form plaques for 7 days. Cells were then fixed with ice-cold methanol and stained with crystal violet. All plaque assays were performed in triplicate. To quantify plaque size, the areas of 50 plaques per condition were measured using ZEN software (Zeiss). To quantify plaque number, the total number of plaques in each condition was counted manually. Graphical and statistical analyses were performed using Prism GraphPad 8.0.

Quantification of defective vacuoles and mislocalized IMC32

For quantification of morphological and replication defects, HFF monolayers grown on glass coverslips were infected with IMC43AID parasites at low MOI -/+ IAA. 24 hours post-infection, coverslips were fixed with 3.7% PFA, processed for immunofluorescence, and labeled with anti-HA and anti-IMC6. For both the -IAA and +IAA conditions, >100 vacuoles spread across at least 10 fields were scored as defective or normal. Vacuoles were scored as defective if they exhibited any of the following defects: desynchronized endodyogeny, >2 daughter buds per cell, immature daughter cells present outside of a maternal cell, gaps in the cytoskeleton marked by IMC6, or severe swelling. The experiment was performed in triplicate. Significance was determined using a two-tailed t-test.

For quantification of mislocalized IMC32, HFF monolayers grown on glass coverslips were infected with IMC323xV5IMC43AID parasites at low MOI -/+ IAA. 18 hours post-infection, coverslips were fixed with 3.7% PFA, processed for immunofluorescence, and labeled with anti-V5 and anti-IMC6. For both the -IAA and +IAA conditions, >100 vacuoles containing parasites at the bud initiation and early budding stages of endodyogeny spread across at least 10 fields were scored as either normal or mislocalized. Vacuoles were scored as mislocalized at these stages if IMC32 signal was not observed in 5 distinct puncta/short stripes arranged in a ring-shape on nascent daughter buds. Then, >100 different vacuoles containing parasites at the mid and late budding stages of endodyogeny were scored as either normal or mislocalized. Vacuoles were scored as mislocalized at these stages if IMC32 signal was not observed in a series of longitudinal stripes along the body of the IMC. The experiment was performed in triplicate. Significance was determined using a two-tailed t-test.

Affinity capture of biotinylated proteins

For affinity capture of proteins from whole cell lysates, HFF monolayers infected with IMC43TurboID or control parasites (RHΔhxgprtΔku80, WT) were grown in medium containing 150 μM biotin for 30 hours. Intracellular parasites in large vacuoles were collected by manual scraping, washed in PBS, and lysed in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40) supplemented with Complete Protease Inhibitor Cocktail (Roche) for 30 min on ice. Lysates were centrifuged for 15 min at 14,000 x g to pellet insoluble material, and the supernatant was incubated with Streptavidin Plus UltraLink resin (Pierce) overnight at 4°C under gentle agitation. Beads were collected and washed five times in RIPA buffer, followed by three washes in 8 M urea buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl) [71]. Samples were submitted for on-bead digests and subsequently analyzed by mass spectrometry. The experiment was performed in duplicate.

Mass spectrometry of biotinylated proteins

Purified proteins bound to streptavidin beads were reduced, alkylated, and digested by sequential addition of Lys-C and trypsin proteases. Samples were then desalted using C18 tips (Pierce) and fractionated online using a 75-μm inner-diameter fritted fused silica capillary column with a 5-μm pulled electrospray tip and packed in-house with 25 cm of C18 (Dr. Maisch GmbH) 1.9-μm reversed-phase particles. The gradient was delivered by a 140-minute gradient of increasing acetonitrile and eluted directly into a Thermo Orbitrap Fusion Lumos instrument where MS/MS spectra were acquired by Data Dependent Acquisition (DDA). Data analysis was performed using ProLuCID and DTASelect2 implemented in Integrated Proteomics Pipeline IP2 (Integrated Proteomics Applications) [7274]. Database searching was performed using a FASTA protein database containing T. gondii GT1-translated open reading frames downloaded from ToxoDB. Protein and peptide identifications were filtered using DTASelect and required a minimum of two unique peptides per protein and a peptide-level false positive rate of less than 5% as estimated by a decoy database strategy. Candidates were ranked by spectal count comparing IMC43TurboID versus control samples [75].

Yeast two-hybrid

Y2H screening was performed by Hybrigenics Services as previously described [40,41]. Briefly, the full-length coding sequence of IMC43 was cloned into the pB35 vector (N-GAL4-bait-C fusion, inducible) and transformed in yeast. This construct was screened for interactions against the T. gondii RH strain cDNA library with 37 million interactions tested. Confidence for each interaction was assessed algorithmically (Predicted Biological Score, PBS).

For pairwise Y2H assays, fragments of IMC43, IMC44, and IMC32 were cloned into the pB27 (N-LexA-bait-C fusion) or pP6 (N-GAL4AD-prey-C fusion) vectors (Hybrigenics Services) as N-terminal fusions with the LexA DNA binding domain or GAL4 activation domain, respectively. All pB27 and pP6 constructs were cloned by Gibson Assembly using primers P68-P101. Pairs of pB27 and pP6 constructs were co-transformed into the L40 strain of S. cerevisiae [MATa his3D200trp1-901 leu2-3112 ade2 LYS2::(4lexAop-HIS3) URA3::(8lexAop-lacZ) GAL4]. Strains were grown overnight in permissive (-Leu/-Trp) medium, normalized to OD600 = 2, then spotted in six serial dilutions onto permissive (-Leu/-Trp) and restrictive (-Leu/-Trp/-His) media. Growth was assessed after 3–5 days.

Supporting information

S1 Fig. Conservation and secondary structure predictions for TGGT1_238895.

A) ToxoDB reports TGGT1_238895 as a 1,654 amino acid protein, with the first two residues being methionine. Alignment of TGGT1_238895 with its N. caninum homolog NCLIV_015750 show that the first methionine (lowercase, bold) in TGGT1_238895 is not conserved. The second methionine (uppercase, bold) and much of the N-terminus is highly conserved. The second methionine is also a more favorable start codon based on the T. gondii consensus translation initiation sequence (A at position -3, G at position +4) [77]. We therefore determined that the protein is likely to start at the second methionine, resulting in TGGT1_238895 encoding a 1,653 amino acid protein. Residues are numbered accordingly in this study. B) The amino acid sequence of IMC43 (TGGT1_238895) was aligned to its N. caninum ortholog NCLIV_015750 using ClustalO 1.2.4. Alpha-helices predicted by PSIPRED are shown above their corresponding sequences. Regions chosen for the deletion series are highlighted.

(TIF)

S2 Fig. IFA showing successful targeting of the IMC43 locus using CRISPR/Cas9.

A) Diagram showing the strategy used to genetically disrupt IMC43 in an IMC433xHA parental line. B) IFA showing that FLAG-positive/HA-negative parasites with severe morphological defects were observed 30 hours after transfection, indicating successful ablation of the target gene. The Δimc43 parasites were rapidly lost from the population and could not be recovered. Arrows point to daughter buds lacking HA staining. Magenta = anti-HA, Green = anti-FLAG detecting Cas93xFLAG, Blue = anti-IMC6. Scale bar = 2 μm.

(TIF)

S3 Fig. Western blots showing depletion and complementation of IMC43AID.

A) Western blot showing efficient depletion of IMC43AID after four hours of IAA treatment. Parasites were grown intracellularly for 24 hours prior to adding IAA. Catalase is used as a loading control. B) Western blot of IMC43AID + IMC43WT parasites after four hours of IAA treatment. IMC43WT expresses at equal levels -/+ IAA. Catalase is used as a loading control. C) Western blots comparing expression levels of IMC43WT with the IMC43 deletion constructs shown in Fig 4A. Catalase was used as a loading control. D) Western blots comparing expression levels of IMC43WT with IMC43Δ1441–1561 and IMC43Δ1562–1653. Catalase was used as a loading control.

(TIF)

S4 Fig. Most IMC43 deletion constructs localize normally to the daughter IMC.

IFAs showing that eight of the IMC43 deletion constructs colocalize with IMC43AID. Magenta = anti-OLLAS detecting IMC43 deletion constructs, Green = anti-HA detecting IMC43AID. Scale bars = 2 μm.

(TIF)

S5 Fig. Most IMC43 deletion constructs rescue the morphological and replication defects observed upon depletion of IMC43.

IFAs showing that eight of the IMC43 deletion constructs fully rescue the morphological and replication defects caused by depletion of IMC43. Magenta = anti-OLLAS detecting IMC43 deletion constructs, Green = anti-IMC6. Scale bars = 2 μm.

(TIF)

S6 Fig. IMC44 is dispensable for the T. gondii lytic cycle and does not impact IMC43 localization.

A) The endogenous locus for IMC44 was disrupted in the IMC443xMyc parent strain. IFA of Δimc44 parasites confirms loss of IMC443xMyc signal. Magenta = anti-Myc, Green = anti-IMC6. B) PCR verification for genomic DNA of WT and Δimc44 parasites. Diagram indicates the binding location of primers used to amplify the IMC44 coding sequencing (blue arrows) and the site of recombination for the knockout (red arrows). C) Plaque assays of WT and Δimc44 parasites. D) Quantification of plaque size for plaque assays shown in panel D. Statistical significance was determined using a two-tailed t test (ns = not significant). E) IFA showing normal localization of IMC43 in Δimc44 parasites. Magenta = anti-Ty detecting IMC432xStrep3xTy, Green = anti-IMC6. Scale bars = 2 μm.

(TIF)

S7 Fig. Most IMC43 deletion constructs rescue the mislocalization of IMC44 caused by depletion of IMC43.

IFAs showing the localization of IMC44 in nine of the IMC43 deletion lines. All nine shown in this figure rescue the mislocalization of IMC44. Magenta = anti-Myc detecting IMC443xMyc, Green = anti-IMC6. Scale bars = 2 μm.

(TIF)

S8 Fig. Depletion of IMC32 has no effect on IMC43 localization.

A) An mAID-3xTy degron tag was fused to the C-terminus of IMC32 in a TIR1-expressing strain to facilitate proteasomal degradation upon treatment with IAA. B) IFA of IMC32AID parasites after 24 hours of growth -/+ IAA. Depletion of IMC32 results in morphological and replication defects as previously described [27]. Magenta = anti-Ty detecting IMC32AID, Green = anti-IMC6. C) IFA showing the localization of IMC43 in IMC32AID parasites after 24 hours of growth -/+ IAA. IMC43 is unaffected by depletion of IMC32. Magenta = anti-HA detecting IMC433xHA, Green = anti-IMC6. Scale bars = 2 μm.

(TIF)

S9 Fig. Most IMC43 deletion constructs rescue the mislocalization of IMC32 caused by depletion of IMC43.

IFAs showing the localization of IMC32 in nine of the IMC43 deletion lines. All nine shown in this figure rescue the mislocalization of IMC32. Magenta = anti-V5 detecting IMC323xV5, Green = anti-IMC6. Scale bars = 2 μm.

(TIF)

S1 Table. Full IMC43TurboID mass spectrometry results.

Full list of genes identified by mass spectrometry in the IMC43TurboID experiment. Spectral counts are shown for each gene. “Enrichment Diff” refers to the difference between the average spectral count in IMC43TurboID and control parasites. “Enrichment Fold” refers to the average spectral count for IMC43TurboID samples divided by the average spectral count for control samples.

(XLSX)

S2 Table. Full IMC43 Y2H screen results.

Full list of genes identified by the Hybrigenics Y2H screen. All clones identified for a specific gene are grouped. Clones that were found to be out-of-frame are greyed out. Global PBS indicates the confidence score assigned to each clone [40,41].

(XLSX)

S3 Table. Oligonucleotides used in this study.

(XLSX)

Acknowledgments

We thank Dominique Soldati-Favre for the catalase antibody, Gary Ward for the IMC1 antibody, and Michael Reese for the pP6 and pB27 plasmids, L40 strain of yeast, and protocols for pairwise Y2H assays. We thank members of the Bradley lab for helpful reading of the manuscript.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by NIH grants AI123360 to P.J.B. and GM089778 to J.A.W. R.R.P and P.S.B were supported by the Ruth L. Kirschstein National Research Service Award GM007185 and UCLA Molecular Biology Institute (MBI) Whitcome Fellowship. R.R.P. was additionally supported by the Ruth L. Kirschstein National Research Service Award AI007323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005. Jun;6(1):41–61. doi: 10.1079/ahr2005100 [DOI] [PubMed] [Google Scholar]
  • 2.Mackintosh CL, Beeson JG, Marsh K. Clinical features and pathogenesis of severe malaria. Trends Parasitol. 2004. Dec;20(12):597–603. doi: 10.1016/j.pt.2004.09.006 [DOI] [PubMed] [Google Scholar]
  • 3.Sow SO, Muhsen K, Nasrin D, Blackwelder WC, Wu Y, Farag TH, et al. The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis. 2016. May;10(5):e0004729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sharman PA, Smith NC, Wallach MG, Katrib M. Chasing the golden egg: vaccination against poultry coccidiosis. Parasite Immunol. 2010. Aug;32(8):590–8. doi: 10.1111/j.1365-3024.2010.01209.x [DOI] [PubMed] [Google Scholar]
  • 5.Kivaria FM. Estimated direct economic costs associated with tick-borne diseases on cattle in Tanzania. Trop Anim Health Prod. 2006. May;38(4):291–9. doi: 10.1007/s11250-006-4181-2 [DOI] [PubMed] [Google Scholar]
  • 6.Dubey JP. Review of Neospora caninum and neosporosis in animals. Korean J Parasitol. 2003. Mar;41(1):1–16. doi: 10.3347/kjp.2003.41.1.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009. Oct;39(12):1385–94. doi: 10.1016/j.ijpara.2009.04.003 [DOI] [PubMed] [Google Scholar]
  • 8.Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000. Nov;30(12–13):1217–58. doi: 10.1016/s0020-7519(00)00124-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Luft BJ, Remington JS. Toxoplasmic Encephalitis in AIDS. Clin Infect Dis. 1992. Aug 1;15(2):211–22. doi: 10.1093/clinids/15.2.211 [DOI] [PubMed] [Google Scholar]
  • 10.Martin S. Congenital Toxoplasmosis. Neonatal Netw. 2001. Jun;20(4):23–30. doi: 10.1891/0730-0832.20.4.23 [DOI] [PubMed] [Google Scholar]
  • 11.Blader IJ, Coleman BI, Chen CT, Gubbels MJ. Lytic Cycle of Toxoplasma gondii: 15 Years Later. Annu Rev Microbiol. 2015;69:463–85. doi: 10.1146/annurev-micro-091014-104100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.D’Haese J, Mehlhorn H, Peters W. Comparative electron microscope study of pellicular structures in coccidia (Sarcocystis, Besnoitia and Eimeria). Int J Parasitol. 1977. Dec;7(6):505–18. doi: 10.1016/0020-7519(77)90014-5 [DOI] [PubMed] [Google Scholar]
  • 13.Mann T, Beckers C. Characterization of the subpellicular network, a filamentous membrane skeletal component in the parasite Toxoplasma gondii. Mol Biochem Parasitol. 2001. Jul;115(2):257–68. doi: 10.1016/s0166-6851(01)00289-4 [DOI] [PubMed] [Google Scholar]
  • 14.Anderson-White BR, Ivey FD, Cheng K, Szatanek T, Lorestani A, Beckers CJ, et al. A family of intermediate filament-like proteins is sequentially assembled into the cytoskeleton of Toxoplasma gondii: IMC proteins in Toxoplasma cell division. Cell Microbiol. 2011. Jan;13(1):18–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Chen AL, Kim EW, Toh JY, Vashisht AA, Rashoff AQ, Van C, et al. Novel components of the Toxoplasma inner membrane complex revealed by BioID. mBio. 2015;6(1):e02357–14. doi: 10.1128/mBio.02357-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chen AL, Moon AS, Bell HN, Huang AS, Vashisht AA, Toh JY, et al. Novel insights into the composition and function of the Toxoplasma IMC sutures. Cell Microbiol. 2016;19(4):e12678. doi: 10.1111/cmi.12678 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gubbels MJ, Keroack CD, Dangoudoubiyam S, Worliczek HL, Paul AS, Bauwens C, et al. Fussing About Fission: Defining Variety Among Mainstream and Exotic Apicomplexan Cell Division Modes. Front Cell Infect Microbiol. 2020. Jun 5;10:269. doi: 10.3389/fcimb.2020.00269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Francia ME, Striepen B. Cell division in apicomplexan parasites. Nat Rev Microbiol. 2014. Feb;12(2):125–36. doi: 10.1038/nrmicro3184 [DOI] [PubMed] [Google Scholar]
  • 19.Chen CT, Gubbels MJ. The Toxoplasma gondii centrosome is the platform for internal daughter budding as revealed by a Nek1 kinase mutant. J Cell Sci. 2013. Aug 1;126(15):3344–55. doi: 10.1242/jcs.123364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Anderson-White B, Beck JR, Chen CT, Meissner M, Bradley PJ, Gubbels MJ. Cytoskeleton assembly in Toxoplasma gondii cell division. Int Rev Cell Mol Biol. 2012;298:1–31. doi: 10.1016/B978-0-12-394309-5.00001-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Suvorova ES, Francia M, Striepen B, White MW. A Novel Bipartite Centrosome Coordinates the Apicomplexan Cell Cycle. Pellman D, editor. PLOS Biol. 2015. Mar 3;13(3):e1002093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Morrissette NS, Sibley LD. Disruption of microtubules uncouples budding and nuclear division in Toxoplasma gondii. J Cell Sci. 2002. Mar 1;115(Pt 5):1017–25. doi: 10.1242/jcs.115.5.1017 [DOI] [PubMed] [Google Scholar]
  • 23.Shaw MK, Compton HL, Roos DS, Tilney LG. Microtubules, but not actin filaments, drive daughter cell budding and cell division in Toxoplasma gondii. J Cell Sci. 2000. Apr 1;113(7):1241–54. [DOI] [PubMed] [Google Scholar]
  • 24.Behnke MS, Wootton JC, Lehmann MM, Radke JB, Lucas O, Nawas J, et al. Coordinated progression through two subtranscriptomes underlies the tachyzoite cycle of Toxoplasma gondii. PloS One. 2010. Aug 26;5(8):e12354. doi: 10.1371/journal.pone.0012354 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ouologuem DT, Roos DS. Dynamics of the Toxoplasma gondii inner membrane complex. J Cell Sci. 2014. Jan 1;jcs.147736. doi: 10.1242/jcs.147736 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Baptista CG, Lis A, Deng B, Gas-Pascual E, Dittmar A, Sigurdson W, et al. Toxoplasma F-box protein 1 is required for daughter cell scaffold function during parasite replication. Gubbels MJ, editor. PLOS Pathog. 2019. Jul 26;15(7):e1007946. doi: 10.1371/journal.ppat.1007946 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Torres JA, Pasquarelli RR, Back PS, Moon AS, Bradley PJ. Identification and Molecular Dissection of IMC32, a Conserved Toxoplasma Inner Membrane Complex Protein That Is Essential for Parasite Replication. mBio. 2021. Feb 23;12(1):e03622–20. doi: 10.1128/mBio.03622-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Engelberg K, Bechtel T, Michaud C, Weerapana E, Gubbels MJ. Proteomic characterization of the Toxoplasma gondii cytokinesis machinery portrays an expanded hierarchy of its assembly and function. Nat Commun. 2022. Aug 8;13(1):4644. doi: 10.1038/s41467-022-32151-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Back PS, Moon AS, Pasquarelli RR, Bell HN, Torres JA, Chen AL, et al. IMC29 Plays an Important Role in Toxoplasma Endodyogeny and Reveals New Components of the Daughter-Enriched IMC Proteome. mBio. 2023. Jan 9;e0304222. doi: 10.1128/mbio.03042-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Back PS, O’Shaughnessy WJ, Moon AS, Dewangan PS, Hu X, Sha J, et al. Ancient MAPK ERK7 is regulated by an unusual inhibitory scaffold required for Toxoplasma apical complex biogenesis. Proc Natl Acad Sci. 2020. Jun 2;117(22):12164–73. doi: 10.1073/pnas.1921245117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tosetti N, Dos Santos Pacheco N, Bertiaux E, Maco B, Bournonville L, Hamel V, et al. Essential function of the alveolin network in the subpellicular microtubules and conoid assembly in Toxoplasma gondii. eLife. 2020. May 7;9:e56635. doi: 10.7554/eLife.56635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Beck JR, Rodriguez-Fernandez IA, Cruz de Leon J, Huynh MH, Carruthers VB, Morrissette NS, et al. A Novel Family of Toxoplasma IMC Proteins Displays a Hierarchical Organization and Functions in Coordinating Parasite Division. Soldati-Favre D, editor. PLoS Pathog. 2010. Sep 9;6(9):e1001094. doi: 10.1371/journal.ppat.1001094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ludwiczak J, Winski A, Szczepaniak K, Alva V, Dunin-Horkawicz S. DeepCoil-a fast and accurate prediction of coiled-coil domains in protein sequences. Bioinforma Oxf Engl. 2019. Aug 15;35(16):2790–5. doi: 10.1093/bioinformatics/bty1062 [DOI] [PubMed] [Google Scholar]
  • 34.Lupas A, Van Dyke M, Stock J. Predicting coiled coils from protein sequences. Science. 1991. May 24;252(5009):1162–4. doi: 10.1126/science.252.5009.1162 [DOI] [PubMed] [Google Scholar]
  • 35.Sidik SM, Huet D, Ganesan SM, Huynh MH, Wang T, Nasamu AS, et al. A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Cell. 2016;166(6):1423–1435.e12. doi: 10.1016/j.cell.2016.08.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Nishimura K, Fukagawa T, Takisawa H, Kakimoto T, Kanemaki M. An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nat Methods. 2009. Dec;6(12):917–22. doi: 10.1038/nmeth.1401 [DOI] [PubMed] [Google Scholar]
  • 37.Brown KM, Long S, Sibley LD. Plasma Membrane Association by N-Acylation Governs PKG Function in Toxoplasma gondii. mBio. 2017;8(3):e00375–17. doi: 10.1128/mBio.00375-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Buchan DWA, Jones DT. The PSIPRED Protein Analysis Workbench: 20 years on. Nucleic Acids Res. 2019. Jul 2;47(W1):W402–7. doi: 10.1093/nar/gkz297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Branon TC, Bosch JA, Sanchez AD, Udeshi ND, Svinkina T, Carr SA, et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat Biotechnol. 2018;36(9):880–7. doi: 10.1038/nbt.4201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rain JC, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S, et al. The protein-protein interaction map of Helicobacter pylori. Nature. 2001. Jan 11;409(6817):211–5. doi: 10.1038/35051615 [DOI] [PubMed] [Google Scholar]
  • 41.Formstecher E, Aresta S, Collura V, Hamburger A, Meil A, Trehin A, et al. Protein interaction mapping: a Drosophila case study. Genome Res. 2005. Mar;15(3):376–84. doi: 10.1101/gr.2659105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Barylyuk K, Koreny L, Ke H, Butterworth S, Crook OM, Lassadi I, et al. A Comprehensive Subcellular Atlas of the Toxoplasma Proteome via hyperLOPIT Provides Spatial Context for Protein Functions. Cell Host Microbe. 2020. Nov;28(5):752–766.e9. doi: 10.1016/j.chom.2020.09.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.He B, Wang K, Liu Y, Xue B, Uversky VN, Dunker AK. Predicting intrinsic disorder in proteins: an overview. Cell Res. 2009. Aug;19(8):929–49. doi: 10.1038/cr.2009.87 [DOI] [PubMed] [Google Scholar]
  • 44.Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021. Aug;596(7873):583–9. doi: 10.1038/s41586-021-03819-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022. Jan 7;50(D1):D439–44. doi: 10.1093/nar/gkab1061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kamtekar S, Hecht MH. Protein Motifs. 7. The four-helix bundle: what determines a fold? FASEB J Off Publ Fed Am Soc Exp Biol. 1995. Aug;9(11):1013–22. doi: 10.1096/fasebj.9.11.7649401 [DOI] [PubMed] [Google Scholar]
  • 47.Lupas AN, Bassler J. Coiled Coils–A Model System for the 21st Century. Trends Biochem Sci. 2017. Feb;42(2):130–40. doi: 10.1016/j.tibs.2016.10.007 [DOI] [PubMed] [Google Scholar]
  • 48.Dos Santos Pacheco N, Tosetti N, Krishnan A, Haase R, Maco B, Suarez C, et al. Revisiting the Role of Toxoplasma gondii ERK7 in the Maintenance and Stability of the Apical Complex. mBio. 2021. Oct 26;12(5):e0205721. doi: 10.1128/mBio.02057-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Gilk SD, Raviv Y, Hu K, Murray JM, Beckers CJM, Ward GE. Identification of PhIL1, a novel cytoskeletal protein of the Toxoplasma gondii pellicle, through photosensitized labeling with 5-[125I]iodonaphthalene-1-azide. Eukaryot Cell. 2006. Oct;5(10):1622–34. doi: 10.1128/EC.00114-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Oliveira Souza RO, Jacobs KN, Back PS, Bradley PJ, Arrizabalaga G. IMC10 and LMF1 mediate mitochondrial morphology through mitochondrion-pellicle contact sites in Toxoplasma gondii. J Cell Sci. 2022. Nov 15;135(22):jcs260083. doi: 10.1242/jcs.260083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Talevich E, Mirza A, Kannan N. Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa. BMC Evol Biol. 2011;11(1):321. doi: 10.1186/1471-2148-11-321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Yang C, Arrizabalaga G. The serine/threonine phosphatases of apicomplexan parasites. Mol Microbiol. 2017. Oct;106(1):1–21. doi: 10.1111/mmi.13715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Guttery DS, Poulin B, Ferguson DJP, Szöőr B, Wickstead B, Carroll PL, et al. A unique protein phosphatase with kelch-like domains (PPKL) in Plasmodium modulates ookinete differentiation, motility and invasion. PLoS Pathog. 2012. Sep;8(9):e1002948. doi: 10.1371/journal.ppat.1002948 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Yang C, Doud EH, Sampson E, Arrizabalaga G. The protein phosphatase PPKL is a key regulator of daughter parasite development in Toxoplasma gondii. BioRxiv [Preprint]; 2023. Jun [cited 2023 Jun 21]. Available from: http://biorxiv.org/lookup/doi/10.1101/2023.06.13.544803 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Berry L, Chen CT, Reininger L, Carvalho TG, El Hajj H, Morlon-Guyot J, et al. The conserved apicomplexan Aurora kinase TgArk3 is involved in endodyogeny, duplication rate and parasite virulence. Cell Microbiol. 2016. Aug;18(8):1106–20. doi: 10.1111/cmi.12571 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Morlon-Guyot J, Berry L, Chen CT, Gubbels MJ, Lebrun M, Daher W. The Toxoplasma gondii calcium-dependent protein kinase 7 is involved in early steps of parasite division and is crucial for parasite survival. Cell Microbiol. 2014. Jan;16(1):95–114. doi: 10.1111/cmi.12186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Donald RG, Roos DS. Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc Natl Acad Sci U S A. 1993. Dec 15;90(24):11703–7. doi: 10.1073/pnas.90.24.11703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kim K, Soldati D, Boothroyd JC. Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker. Science. 1993. Nov 5;262(5135):911–4. doi: 10.1126/science.8235614 [DOI] [PubMed] [Google Scholar]
  • 59.Donald RG, Carter D, Ullman B, Roos DS. Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene: Use as a selectable marker for stable transformation. J Biol Chem. 1996. Jun 14;271(24):14010–9. [DOI] [PubMed] [Google Scholar]
  • 60.Donald RG, Roos DS. Insertional mutagenesis and marker rescue in a protozoan parasite: cloning of the uracil phosphoribosyltransferase locus from Toxoplasma gondii. Proc Natl Acad Sci U S A. 1995. Jun 6;92(12):5749–53. doi: 10.1073/pnas.92.12.5749 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Bastin P, Bagherzadeh Z, Matthews KR, Gull K. A novel epitope tag system to study protein targeting and organelle biogenesis in Trypanosoma brucei. Mol Biochem Parasitol. 1996. May;77(2):235–9. doi: 10.1016/0166-6851(96)02598-4 [DOI] [PubMed] [Google Scholar]
  • 62.Evan GI, Lewis GK, Ramsay G, Bishop JM. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol. 1985. Dec;5(12):3610–6. doi: 10.1128/mcb.5.12.3610-3616.1985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Viswanathan S, Williams ME, Bloss EB, Stasevich TJ, Speer CM, Nern A, et al. High-performance probes for light and electron microscopy. Nat Methods. 2015. Jun;12(6):568–76. doi: 10.1038/nmeth.3365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Choi CP, Moon AS, Back PS, Jami-Alahmadi Y, Vashisht AA, Wohlschlegel JA, et al. A photoactivatable crosslinking system reveals protein interactions in the Toxoplasma gondii inner membrane complex. PLOS Biol. 2019. Oct 4;17(10):e3000475. doi: 10.1371/journal.pbio.3000475 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Wichroski MJ, Melton JA, Donahue CG, Tweten RK, Ward GE. Clostridium septicum alpha-toxin is active against the parasitic protozoan Toxoplasma gondii and targets members of the SAG family of glycosylphosphatidylinositol-anchored surface proteins. Infect Immun. 2002. Aug;70(8):4353–61. doi: 10.1128/IAI.70.8.4353-4361.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Fung C, Beck JR, Robertson SD, Gubbels MJ, Bradley PJ. Toxoplasma ISP4 is a central IMC sub-compartment protein whose localization depends on palmitoylation but not myristoylation. Mol Biochem Parasitol. 2012. Aug;184(2):99–108. doi: 10.1016/j.molbiopara.2012.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Bullen HE, Jia Y, Yamaryo-Botté Y, Bisio H, Zhang O, Jemelin NK, et al. Phosphatidic Acid-Mediated Signaling Regulates Microneme Secretion in Toxoplasma. Cell Host Microbe. 2016. Mar 9;19(3):349–60. doi: 10.1016/j.chom.2016.02.006 [DOI] [PubMed] [Google Scholar]
  • 68.Sidik SM, Hackett CG, Tran F, Westwood NJ, Lourido S. Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9. Blader IJ, editor. PLoS ONE. 2014. Jun 27;9(6):e100450. doi: 10.1371/journal.pone.0100450 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Huynh MH, Carruthers VB. Tagging of endogenous genes in a Toxoplasma gondii strain lacking Ku80. Eukaryot Cell. 2009. Apr;8(4):530–9. doi: 10.1128/EC.00358-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Bradley PJ, Ward C, Cheng SJ, Alexander DL, Coller S, Coombs GH, et al. Proteomic Analysis of Rhoptry Organelles Reveals Many Novel Constituents for Host-Parasite Interactions in Toxoplasma gondii. J Biol Chem. 2005. Oct;280(40):34245–58. doi: 10.1074/jbc.M504158200 [DOI] [PubMed] [Google Scholar]
  • 71.Bradley PJ, Rayatpisheh S, Wohlschlegel JA, Nadipuram SM. Using BioID for the Identification of Interacting and Proximal Proteins in Subcellular Compartments in Toxoplasma gondii. Methods Mol Biol Clifton NJ. 2020;2071:323–46. doi: 10.1007/978-1-4939-9857-9_18 [DOI] [PubMed] [Google Scholar]
  • 72.Xu T, Park SK, Venable JD, Wohlschlegel JA, Diedrich JK, Cociorva D, et al. ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity. J Proteomics. 2015. Nov 3;129:16–24. doi: 10.1016/j.jprot.2015.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Tabb DL, McDonald WH, Yates JR. DTASelect and Contrast: Tools for Assembling and Comparing Protein Identifications from Shotgun Proteomics. J Proteome Res. 2002. Feb 1;1(1):21–6. doi: 10.1021/pr015504q [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Cociorva D, L. Tabb D, Yates JR. Validation of Tandem Mass Spectrometry Database Search Results Using DTASelect. Curr Protoc Bioinforma. 2006;16(1):13.4.1–13.4.14. [DOI] [PubMed] [Google Scholar]
  • 75.Florens L, Carozza MJ, Swanson SK, Fournier M, Coleman MK, Workman JL, et al. Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors. Methods. 2006. Dec 1;40(4):303–11. doi: 10.1016/j.ymeth.2006.07.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Straub KW, Cheng SJ, Sohn CS, Bradley PJ. Novel components of the Apicomplexan moving junction reveal conserved and coccidia-restricted elements. Cell Microbiol. 2009. Apr;11(4):590–603. doi: 10.1111/j.1462-5822.2008.01276.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Seeber F. Consensus sequence of translational initiation sites from Toxoplasma gondii genes. Parasitol Res. 1997;83(3):309–11. doi: 10.1007/s004360050254 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Dominique Soldati-Favre, Christopher J Tonkin

23 Aug 2023

Dear Prof Bradley,

Thank you very much for submitting your manuscript "Identification of IMC43, a novel IMC protein that collaborates with IMC32 to form an essential daughter bud initiation complex in Toxoplasma gondii" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

I am returning your manuscript with three reviews. The reviewers were very positive about the quality and impact of the work of the manuscript. There are some minor aspects that I would like to you to address to prepare the manuscript for publication. No new experiments are required.

In particular, I'd like you to consider reviewer 2's points:

1. Re: the title of your manuscript. Please revise the title or provide justification as to why you think it should not be.

2. Please justify why you used the time point of 24hrs of IAA treatment given the fast knockdown and consider including this justification into the manuscript.

3. You are not required to perform additional IFAs looking at the location of the suture proteins, ISC and TSCs, unless you would like to.

4. No super resolution or additional experimentation to dissect out localisation of IMC43 truncation mutants are required.

Please also address point-by-point all other queries and modify the text of the manuscript accordingly.

If all the following items are addressed, I hope to be able to make a final decision without sending the manuscript out for a second round of review.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Christopher J. Tonkin

Guest Editor

PLOS Pathogens

Dominique Soldati-Favre

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

I am returning your manuscript with three reviews. The reviewers were very positive about the quality and impact of the work of the manuscript. There are some minor aspects that I would like to you to address to prepare the manuscript for publication. No new experiments are required.

In particular, I'd like you to consider reviewer 2's points:

1. Re: the title of your manuscript. Please revise the title or provide justification as to why you think it should not be.

2. Please justify why you used the time point of 24hrs of IAA treatment given the fast knockdown and consider including this justification into the manuscript.

3. You are not required to perform additional IFAs looking at the location of the suture proteins, ISC and TSCs, unless you would like to.

4. No super resolution or additional experimentation to dissect out localisation of IMC43 truncation mutants are required.

Please also address point-by-point all other queries and modify the text of the manuscript accordingly.

If all the following items are addressed, I hope to be able to make a final decision without sending the manuscript out for a second round of review.

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: The authors here present new work uncovering the functions of the alveolin proteins of Toxoplasma gondii. The authors show that conditional depletion of a novel protein, IMC43, leads to a severe defect in replication, characterised by issues in cell morphology and cell cycle control. Through elegant complementation experiments, they identify a region in the C-terminus of IMC43 required for its function, and that this region mediates interactions between IMC43 and two other IMC proteins, IMC32 and IMC44. The authors go into detail identifying the roles of IMC44 and investigate IMC32, a previously studied protein which they show here relies on IMC43 for correct localisation to daughter cell buds.

This work is very well performed and presented and provides new information about the organisation of daughter cell budding in Toxoplasma endodyogeny. The manuscript is of high quality and I believe is suitable for immediate publication. I would like to congratulate the authors on really great work.

Reviewer #2: The manuscript by Pasquarelli et al. characterizes a novel T. gondii IMC protein, IMC43. IMC43 was identified by previous IMC29 BioID experiments carried out in the Bradley lab (PMID: 36622147) and shares localization and dynamics with other markers of the daughter cell scaffold, a structure that represents the earliest daughter bud assembly.

Conditional depletion of IMC43 leads to morphological and division defects, with parasites exhibiting severely impaired proliferation. Attempts to disrupt the ORF were unsuccessful indicating that IMC43 is essential. The authors dissect IMC43 function by creating nine deletion mutants and identify a 120 aa long region at the c-terminus necessary for its function. Combining data from IMC43 BioID experiments and an IMC43 Y2H screen, the author shortlist 30 genes and follow up on two, IMC32 and the so far uncharacterized IMC44. Taking advantage of the IMC43 conditional depletion system and the identified loss of function mutant, the authors show that IMC43 is needed for correct localization of IMC32 and 44 in the mid/late budding stage. IMC43’s essential function therefore seems to be maintaining daughter bud integrity during endodoyogeny.

How daughter buds form and which genes contribute to the process is still not understood in detail, neither in T. gondii nor in Apicomplexa in general and this manuscript makes an important contribution by carefully characterizing a novel IMC protein. Overall, this is a nicely carried out study with well-controlled experiments. The presented images allow adequate interpretation of the results and the combination of BioID and Y2H screening exhibits a good strategy toward identifying interacting proteins in the parasite. The specific comments are as follows:

Reviewer #3: This is a very well executed study that characterizes the Toxoplasma gondii protein IMC43. This protein is part of the inner membrane complex of budding cells and is essential for parasite division. Toxoplasma divides by a unique mechanism known as endodyogeny and the discovery of proteins essential for the process advances the field significantly. The work presented is a thorough characterization of the localization, function, and interactors of IMC43. The experiments presented are well executed, controlled for, and carefully interpreted. The data presented is convincing and provides great insight into the scaffold that allows for parasite division. There are no major concerns about the manuscript, only a few minor details that could use clarification.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: No new experiments are required

Reviewer #2: 1)The authors should consider revising the title of the manuscript, as neither IMC43 nor IMC32 is functionally involved in daughter bud initiation (buds still form when proteins are conditionally depleted, e.g. Fig 1A/C, Fig S8 B/C). Although both proteins localize to the DCS, naming the complex “essential daughter bud initiation complex” may be slightly overreaching.

2) The authors use a fast acting auxin-inducible degron system and show that IMC43 is depleted after 4 hrs of IAA treatment (Fig S3B). However, the phenotypic analyses are done mostly after 24 hrs of IAA treatment, allowing parasites to undergo several rounds of division. Did the authors detect any aberrations in 4 hr IAA treated parasites that would indicate primary defects of IMC43 depletion?

3) Upon IMC43AID depletion IMC32 looses its striped pattern on daughter buds (Fig 7D/E). Have the author tested the impact of IMC43 depletion on other proteins (e.g. suture proteins ISCs and TSCs [PMID 27696623]) that have been reported to localize to similar striped patterns in daughter/mature parasites ?

Reviewer #3: None noted

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: No minor points

Reviewer #2: - The authors use state of the art microscopy that clearly allows result interpretation. However, given the small size of certain parasite structures that are difficult to resolve with conventional light microscopy, have the authors considered applying super-resolution microscopy (e.g. 3D-SIM)?

This will most likely facilitate better resolution of the earliest IMC43 appearances (Fig 1G/J), where the signal seems to concentrate in distinct foci before decorating the forming daughter bud. Super-resolution imaging would further allow mapping the spatial relations of DCS constituents during bud initiation (specifically the IMC32/IMC43 relation).

- The IMC43 ∆1441-1561 deletion mutant still localizes to daughter buds although it fails to rescue the phenotype caused by IMC43AID depletion. Have the authors considered tagging the ∆1441-1561 deletion mutant with TurboID and create a BioID experiment after IMC43AID depletion? This would likely expand the list of candidates that rely on IMC43 for association with daughter buds when compared to IMC43wt BioID.

- In the IMC43AID-depleted background, does IMC44 already localize to the basal complex at bud initiation and the early budding stages, or is basal complex association timing preserved in absence of IMC43? Images provided in Fig 6E seem to correspond to the mid budding stage and do not allow this assessment.

Edits:

-line 52: change Apicomplexans to Apicomplexa

-lines 65-67: Apicomplexa use external or internal budding strategies, which should be either reflected in the sentence or “internal” be deleted.

-line 79: see above comment, I suggest deleting “internal” from this sentence and move it to the next one (lines 80-82)

-line 452: “HXGPRT” is used as abbreviation for hypoxanthine-xanthine-guanine phosphoribosyltransferase while lines 472-474 use “HPT”, this should be made uniform.

-Fig 1G: Three of the four mature parasites seem to form only a single daughter, is that correct?

-line 653; Change “Asterisk indicates daughter apical caps.” to “Asterisk indicates daughter buds”, as the asterisk does not seem to clearly point to the apical cap of the daughter.

-line 685: Please fix cross-reference for plaque assays, legends says “J” but plaque assays are shown as panel “H” of Figure 2.

-line 688: Same as above, please correct to panel “H”.

-line 691: Delete the second scale bar sentence.

-Fig 3: Please add IAA treatment time to figure legend and/or corresponding result section.

-Fig 3: Please indicate scale bar size in the figure or legend.

-Fig 3D: The - IAA “merge” image also shows the Hoechst signal in Blue, please add the corresponding Hoechst signal for the +IAA treated “merge” images as well.

-Fig 3E: This reviewer feels that the message of continues nuclear division would be stronger if Hoechst signal is also shown for images in Fig 2E, taking advantage of the longer 40 hr IAA treatment time.

-Fig 5D/Table S1: The table in the figure and the Supp. Table 1 show candidate abundance as spectral counts, while the methods (line 600) state that “candidates were ranked by normalized spectral abundance factor values…..”. This should be made uniform or alternatively, provide normalized spectral abundance factor values in Table S1.

-Fig 5D: Since the authors reference the PPKL preprint in the discussion (lines 427-428), please add a reference in the “Localization” column of the figure as well.

-Figure S2: A schematic showing where IMC43 gRNA binds and CRISPR/Cas9 double strand break occurs will enhance understanding of this figure. Please also add dimension of the scale bar to the figure or the legend.

-Figure S3: Please label western blots molecular weight with “kDa”

Reviewer #3: It is interesting that the IMC43 kd results in defects in the cytoskeleton of the mother parasite. Since IMC43 is exclusively in the daughter buds this is interesting and might warrant some discussion or speculation.

There might be a need for some clarity in line 216 where it says ‘the fusion protein is active’. Given the data presented I imagine this means that the TurboID part of the fusion is active (i.e it biotinylates). Did they test the fusion in the KD strain to know that it rescues the phenotype? That would be needed to be able to say that the IMC43 part of the fusion is active. This is not needed, but some clarity about what it is meant by the ‘fusion protein is active’ might be helpful.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Decision Letter 1

Dominique Soldati-Favre, Christopher J Tonkin

23 Sep 2023

Dear Prof Bradley,

We are pleased to inform you that your manuscript 'Identification of IMC43, a novel IMC protein that collaborates with IMC32 to form an essential daughter bud assembly complex in Toxoplasma gondii' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Christopher J. Tonkin

Guest Editor

PLOS Pathogens

Dominique Soldati-Favre

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Acceptance letter

Dominique Soldati-Favre, Christopher J Tonkin

28 Sep 2023

Dear Prof Bradley,

We are delighted to inform you that your manuscript, "Identification of IMC43, a novel IMC protein that collaborates with IMC32 to form an essential daughter bud assembly complex in Toxoplasma gondii," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Conservation and secondary structure predictions for TGGT1_238895.

    A) ToxoDB reports TGGT1_238895 as a 1,654 amino acid protein, with the first two residues being methionine. Alignment of TGGT1_238895 with its N. caninum homolog NCLIV_015750 show that the first methionine (lowercase, bold) in TGGT1_238895 is not conserved. The second methionine (uppercase, bold) and much of the N-terminus is highly conserved. The second methionine is also a more favorable start codon based on the T. gondii consensus translation initiation sequence (A at position -3, G at position +4) [77]. We therefore determined that the protein is likely to start at the second methionine, resulting in TGGT1_238895 encoding a 1,653 amino acid protein. Residues are numbered accordingly in this study. B) The amino acid sequence of IMC43 (TGGT1_238895) was aligned to its N. caninum ortholog NCLIV_015750 using ClustalO 1.2.4. Alpha-helices predicted by PSIPRED are shown above their corresponding sequences. Regions chosen for the deletion series are highlighted.

    (TIF)

    S2 Fig. IFA showing successful targeting of the IMC43 locus using CRISPR/Cas9.

    A) Diagram showing the strategy used to genetically disrupt IMC43 in an IMC433xHA parental line. B) IFA showing that FLAG-positive/HA-negative parasites with severe morphological defects were observed 30 hours after transfection, indicating successful ablation of the target gene. The Δimc43 parasites were rapidly lost from the population and could not be recovered. Arrows point to daughter buds lacking HA staining. Magenta = anti-HA, Green = anti-FLAG detecting Cas93xFLAG, Blue = anti-IMC6. Scale bar = 2 μm.

    (TIF)

    S3 Fig. Western blots showing depletion and complementation of IMC43AID.

    A) Western blot showing efficient depletion of IMC43AID after four hours of IAA treatment. Parasites were grown intracellularly for 24 hours prior to adding IAA. Catalase is used as a loading control. B) Western blot of IMC43AID + IMC43WT parasites after four hours of IAA treatment. IMC43WT expresses at equal levels -/+ IAA. Catalase is used as a loading control. C) Western blots comparing expression levels of IMC43WT with the IMC43 deletion constructs shown in Fig 4A. Catalase was used as a loading control. D) Western blots comparing expression levels of IMC43WT with IMC43Δ1441–1561 and IMC43Δ1562–1653. Catalase was used as a loading control.

    (TIF)

    S4 Fig. Most IMC43 deletion constructs localize normally to the daughter IMC.

    IFAs showing that eight of the IMC43 deletion constructs colocalize with IMC43AID. Magenta = anti-OLLAS detecting IMC43 deletion constructs, Green = anti-HA detecting IMC43AID. Scale bars = 2 μm.

    (TIF)

    S5 Fig. Most IMC43 deletion constructs rescue the morphological and replication defects observed upon depletion of IMC43.

    IFAs showing that eight of the IMC43 deletion constructs fully rescue the morphological and replication defects caused by depletion of IMC43. Magenta = anti-OLLAS detecting IMC43 deletion constructs, Green = anti-IMC6. Scale bars = 2 μm.

    (TIF)

    S6 Fig. IMC44 is dispensable for the T. gondii lytic cycle and does not impact IMC43 localization.

    A) The endogenous locus for IMC44 was disrupted in the IMC443xMyc parent strain. IFA of Δimc44 parasites confirms loss of IMC443xMyc signal. Magenta = anti-Myc, Green = anti-IMC6. B) PCR verification for genomic DNA of WT and Δimc44 parasites. Diagram indicates the binding location of primers used to amplify the IMC44 coding sequencing (blue arrows) and the site of recombination for the knockout (red arrows). C) Plaque assays of WT and Δimc44 parasites. D) Quantification of plaque size for plaque assays shown in panel D. Statistical significance was determined using a two-tailed t test (ns = not significant). E) IFA showing normal localization of IMC43 in Δimc44 parasites. Magenta = anti-Ty detecting IMC432xStrep3xTy, Green = anti-IMC6. Scale bars = 2 μm.

    (TIF)

    S7 Fig. Most IMC43 deletion constructs rescue the mislocalization of IMC44 caused by depletion of IMC43.

    IFAs showing the localization of IMC44 in nine of the IMC43 deletion lines. All nine shown in this figure rescue the mislocalization of IMC44. Magenta = anti-Myc detecting IMC443xMyc, Green = anti-IMC6. Scale bars = 2 μm.

    (TIF)

    S8 Fig. Depletion of IMC32 has no effect on IMC43 localization.

    A) An mAID-3xTy degron tag was fused to the C-terminus of IMC32 in a TIR1-expressing strain to facilitate proteasomal degradation upon treatment with IAA. B) IFA of IMC32AID parasites after 24 hours of growth -/+ IAA. Depletion of IMC32 results in morphological and replication defects as previously described [27]. Magenta = anti-Ty detecting IMC32AID, Green = anti-IMC6. C) IFA showing the localization of IMC43 in IMC32AID parasites after 24 hours of growth -/+ IAA. IMC43 is unaffected by depletion of IMC32. Magenta = anti-HA detecting IMC433xHA, Green = anti-IMC6. Scale bars = 2 μm.

    (TIF)

    S9 Fig. Most IMC43 deletion constructs rescue the mislocalization of IMC32 caused by depletion of IMC43.

    IFAs showing the localization of IMC32 in nine of the IMC43 deletion lines. All nine shown in this figure rescue the mislocalization of IMC32. Magenta = anti-V5 detecting IMC323xV5, Green = anti-IMC6. Scale bars = 2 μm.

    (TIF)

    S1 Table. Full IMC43TurboID mass spectrometry results.

    Full list of genes identified by mass spectrometry in the IMC43TurboID experiment. Spectral counts are shown for each gene. “Enrichment Diff” refers to the difference between the average spectral count in IMC43TurboID and control parasites. “Enrichment Fold” refers to the average spectral count for IMC43TurboID samples divided by the average spectral count for control samples.

    (XLSX)

    S2 Table. Full IMC43 Y2H screen results.

    Full list of genes identified by the Hybrigenics Y2H screen. All clones identified for a specific gene are grouped. Clones that were found to be out-of-frame are greyed out. Global PBS indicates the confidence score assigned to each clone [40,41].

    (XLSX)

    S3 Table. Oligonucleotides used in this study.

    (XLSX)

    Attachment

    Submitted filename: Response Letter.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS Pathogens are provided here courtesy of PLOS

    RESOURCES